FindTrial
Sign In

To study the effectiveness of virtual reality based exercises on balance, dizziness, nystagmus and quality of life in patients with posterior canal benign paroxysmal positional vertigo

Therapeutic effectiveness of virtual reality-based exercise through Oculus Quest 2 on balance, dizziness, nystagmus and quality of life in patients with posterior canal benign paroxysmal positional vertigo -A randomized control trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053111
Enrollment
74
Registered
2023-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H811- Benign paroxysmal vertigo

Interventions

Intervention1: VR based exercise through oculus quest 2 adjunct to conventional therapy: Virtual reality gaming systems construct a simulation model that gives players the impression that they are in

Sponsors

Ravi Nair Physiotherapy College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both Males and Females between 20 to 50 years, diagnosed will positive Loaded Dix-Hallpike test for PC-BPPV. 2. Patients with Dizziness Handicap Inventory score 3. Patients who are willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with Central vestibular dysfunction, Cerebellar dysfunction, Cognitive impairments, and migraines. 2. Patients with Dizziness Handicap Inventory score >= 52 3. Patients with inner ear infections and auditory dysfunctions. 4. Patients under medications. 5. Enrolment in another clinical trial involving physiotherapy or an investigational drug.

Design outcomes

Primary

MeasureTime frame
1.Berg Balance Scale (BBS) 2.Dizziness Handicap Inventory (DHI) 3.Quality of Life Scale (QOLS) 4.Nystagmus time Timepoint: 1.Berg Balance Scale (BBS) at baseline and 4 weeks. 2.Dizziness Handicap Inventory (DHI) at baseline and 4 weeks. 3.Quality of Life Scale (QOLS) at baseline and 4 weeks. 4.Nystagmus time at baseline and 4 weeks.—

Secondary

MeasureTime frame
1. Vertigo Symptom Scale Short FormTimepoint: At baseline and after 4 weeks—

Countries

India

Contacts

Public ContactShrushti Jachak

Ravi Nair Physiotherapy College, Datta Meghe Institute of Higher Education and Research.

raghuneuro@yahoo.com8126506769

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026